SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-061031
Filing Date
2023-07-31
Accepted
2023-07-31 09:00:08
Documents
13
Period of Report
2023-07-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea182603-8k_bluewater.htm   iXBRL 8-K 31591
2 PRESS RELEASE, DATED JULY 31, 2023 ea182603ex99-1_bluewater.htm EX-99.1 16329
  Complete submission text file 0001213900-23-061031.txt   229085

Data Files

Seq Description Document Type Size
3 XBRL LABEL FILE bwv-20230731_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bwv-20230731_pre.xml EX-101.PRE 22358
5 XBRL SCHEMA FILE bwv-20230731.xsd EX-101.SCH 3012
7 EXTRACTED XBRL INSTANCE DOCUMENT ea182603-8k_bluewater_htm.xml XML 3472
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Blue Water Biotech, Inc. (Filer) CIK: 0001782107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41294 | Film No.: 231125194
SIC: 2834 Pharmaceutical Preparations